A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma
Clinical trial NCT02738489 · COMPLETED
Trial details
- NCT number
- NCT02738489
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-13
- Primary completion
- 2020-01-08
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.